NYSE · MD

Pediatrix Medical Group, Inc.

$26.14 -$0.12 (-0.46%) 1D After hours
Session Pulse Pre-market 1 mentions on Fri No new SEC filings since Mon close its sector ranked 5/11 this week Full pulse →
Charting by TradingView

Key Metrics

$2.16B
Market cap
12.38×
P/E · TTM
—
Revenue · TTM
$174.22M
Net income
EPS · TTM $2.04
Dividend yield —
Free cash flow —
Beta · 1Y 0.72
EBITDA · TTM $249.80M
Gross margin —

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 24
    A material event was filed (Form 8-K).

    8-K - Pediatrix Medical Group, Inc. (0000893949) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Feb 19
    The stock moved -12.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 19

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.16B
Enterprise value$2.42B
Shares outstanding82.1M
52-wk range$11.84 – $27.94
Avg volume · 20D740.5K
Net cash −$261.80M
Book value / share$10.28
IndustryServices-Hospitals
ExchangeNYSE
About Pediatrix Medical Group, Inc.
IPO dateMar 31, 1959
Employees2260

Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E12.38
P/S—
P/FCF—
EV/EBITDA9.68
EV/Sales—
Graham №$21.72

Profitability

Gross —
Operating —
Net —
FCF —
ROE / ROIC 21.2% · 15.3%

Financial Health

Current ratio1.33
Quick ratio—
Debt / equity0.67
Debt / EBITDA 2.36
Net cash −$261.80M
Working capital$144.40M

Cash Flow · TTM

Operating CF $258.71M
Capex —
Free cash flow —
Buybacks $106.57M
Dividends paid —
Shareholder yield 4.9%

Piotroski F-Score

6 / 9
Middling fundamentals · 6 of 9 signals passing

Altman Z-Score

—
Insufficient balance-sheet inputs

Graham Number vs Price

$21.72 vs $26.14
Trades 1.2× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings